ClinicalTrials.gov record
Completed Phase 3 Interventional

A Randomized, Comparative Study of Daily Dapsone and Daily Atovaquone for Prophylaxis Against PCP in HIV-Infected Patients Who Are Intolerant of Trimethoprim and/or Sulfonamides

ClinicalTrials.gov ID: NCT00000802

Public ClinicalTrials.gov record NCT00000802. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 19, 2026, 9:07 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Study identification

NCT ID
NCT00000802
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
NIH
Enrollment
700 participants

Conditions and interventions

Interventions

  • Atovaquone Drug
  • Dapsone Drug

Drug

Eligibility (public fields only)

Age range
13 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Not listed
Primary completion
Not listed
Completion
Jun 30, 1997
Last update posted
Nov 3, 2021

Ends 1997

United States locations

U.S. sites
43
U.S. states
20
U.S. cities
33
Facility City State ZIP Site status
Alabama Therapeutics CRS Birmingham Alabama 35294
USC CRS Los Angeles California 900331079
Stanford CRS Palo Alto California 943055107
Ucsd, Avrc Crs San Diego California 921036325
Ucsf Aids Crs San Francisco California 941102859
Santa Clara Valley Med. Ctr. San Jose California 951282699
San Mateo County AIDS Program San Mateo California
Harbor-UCLA Med. Ctr. CRS Torrance California 90502
University of Colorado Hospital CRS Aurora Colorado 80262
Howard University Hosp., Div. of Infectious Diseases, ACTU Washington D.C. District of Columbia 20059
Univ. of Miami AIDS CRS Miami Florida 331361013
Emory Univ. Hemophilia Program Office Atlanta Georgia 303652225
Queens Med. Ctr. Honolulu Hawaii 96816
Univ. of Hawaii at Manoa, Leahi Hosp. Honolulu Hawaii 96816
Northwestern University CRS Chicago Illinois 60611
Cook County Hosp. CORE Ctr. Chicago Illinois 60612
Rush Univ. Med. Ctr. ACTG CRS Chicago Illinois 60612
Weiss Memorial Hosp. Chicago Illinois 60640
Indiana Univ. School of Medicine, Infectious Disease Research Clinic Indianapolis Indiana 462025250
Univ. of Iowa Healthcare, Div. of Infectious Diseases Iowa City Iowa 52242
Johns Hopkins Adult AIDS CRS Baltimore Maryland 21287
Bmc Actg Crs Boston Massachusetts 02118
Beth Israel Deaconess - East Campus A0102 CRS Boston Massachusetts 02215
Massachusetts General Hospital ACTG CRS Boston Massachusetts
Hennepin County Med. Ctr., Div. of Infectious Diseases Minneapolis Minnesota 55415
University of Minnesota, ACTU Minneapolis Minnesota 55455
St. Louis ConnectCare, Infectious Diseases Clinic St Louis Missouri
Washington U CRS St Louis Missouri
Univ. of Nebraska Med. Ctr., Durham Outpatient Ctr. Omaha Nebraska
SUNY - Buffalo, Erie County Medical Ctr. Buffalo New York 13210
Beth Israel Med. Ctr. (Mt. Sinai) New York New York
NY Univ. HIV/AIDS CRS New York New York
Univ. of Rochester ACTG CRS Rochester New York 14642
Unc Aids Crs Chapel Hill North Carolina
Carolinas HealthCare System, Carolinas Med. Ctr. Charlotte North Carolina 28203
Regional Center for Infectious Disease, Wendover Medical Center CRS Greensboro North Carolina 27401
Wake County Health and Human Services CRS Raleigh North Carolina 27610
Univ. of Cincinnati CRS Cincinnati Ohio
Case CRS Cleveland Ohio 44106
MetroHealth CRS Cleveland Ohio
The Ohio State Univ. AIDS CRS Columbus Ohio 432101228
Hosp. of the Univ. of Pennsylvania CRS Philadelphia Pennsylvania 19104
University of Washington AIDS CRS Seattle Washington 981224304

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00000802, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 3, 2021 · Synced May 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00000802 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →